Dr. Deniz Tschammler - McDermott Will & Emery


Deniz Tschammler advises at the pulse of the global health markets. His clients include pharmaceutical and medical technology companies, providers of digital health solutions and their investors. Deniz assists organizations on transactions and collaborations, on market entry and access, on digitization strategies, in disputes with competitors and authorities as well as industry-specific compliance matters. He regularly advises on cross-border projects, including foreign trade law and investment control.

Show More


Deniz advised:

  • Main Capital on the Acquisition of a Majority Stake in Buchner & Camp Partner
  • Oakley Capital on Acquisition of Flemming Dental, Excent & Artinorway Group
  • Elos Medtech on combination with Klingel Medical Group

Show More


  • WWL, “among the highest-ranked Lawyer´s”: Life Sciences, 2024
  • Chambers Europe, “up and coming” in Germany: Life Sciences, 2024
  • The Best Lawyers in Germany, Pharmaceuticals Law, 2022-2024
  • Thomson Reuters, “Stand-out Lawyer” – independently rated lawyers, 2023-2024
  • The Legal 500 EMEA, “Next Generation Partner” in Germany: Healthcare, 2024

Show More


  • Association for the Promotion of the Research Center for Pharmaceutical Law at the Philipps-University of Marburg
  • German-American Lawyers Association
  • German Pharmaceutical Industry Association (BPI)


University of St. Gallen, Executive MBA, 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, Dr. jur., 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007